While it’s too soon to say that the drug is useless, it has clearly been overhyped
By Nathan Geffen and Elsabé Brits
Science | 5 July 2021
UCT and MRC researchers found that dozens of deaths a day were averted by restrictions
Science | 3 July 2021
The regulatory authority must act in the public interest and not be swayed by undue pressure
By Nathan Geffen and Michael Cherry
Science | 23 June 2021
They have misrepresented Anthony Fauci’s correspondence and cast aspersions on Glenda Gray
By Eduard Grebe
Science | 6 June 2021
The death rate was 48% compared to the global average of 32%
Science | 21 May 2021
Interrupting a programme early leads to many more infections than one might naively estimate
By Alex Welte and Rachid Ouifki
Science | 21 April 2021
Quality of water bodies has declined over 40 years
Science | 9 April 2021
Researchers find higher rates of still births and maternal deaths
Science | 7 April 2021
Starting a lockdown too early or too late reduces the benefits but not the hardships
By Alex Welte
Science | 31 March 2021
“South Africa has squandered the opportunity to protect half a million of its most vulnerable citizens”
Science | 26 March 2021
The drug has failed to prevent or treat the disease, and it has lots of side-effects
Science | 12 March 2021
Waste treatment plants across the city are being monitored weekly
Science | 10 March 2021
The first substantial peer-reviewed clinical trial of the drug against Covid-19 finds no evidence that it is a wonder medicine
Science | 8 March 2021
If you have antibodies to the 501Y.V2 variant, you likely have protection against other strains of the virus
Science | 4 March 2021
Concern raised about missed production target, but Professor Glenda Gray says it’s a well-oiled company and they know what they have to do
Science | 25 February 2021